Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation.
Ohba
M
M
Department of Experimental Surgery and Bioengineering, National Children's Medical Research Center, Tokyo, Japan.
Li
X K
XK
Kita
Y
Y
Tamura
A
A
Enosawa
S
S
Sasakuri
S
S
Ogoshi
S
S
Amemiya
H
H
Suzuki
S
S
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000008:administration & dosage / Q000627:therapeutic use*; D060908:CTLA-4 Antigen; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007432:Intraoperative Period; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D011409:Propylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013110:Sphingosine / Q000031:analogs & derivatives; D013997:Time Factors
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000069594:Abatacept; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine